A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Clinical trial NCT02999477 · COMPLETED
Trial details
- NCT number
- NCT02999477
- Sponsor
- Adrienne G. Waks
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2022-11-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.